2018 annual financial data

Capricor Therapeutics, Inc. 2018 Operating margin

Capricor Therapeutics, Inc. 2018 operating margin with verified reported values.

Direct answer

Operating margin was -917.04%.

Operating income was -15,327,086 USD and net income was -15,191,095 USD.
Operating cash flow was -13,862,441 USD.

Get free Capricor Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,671,356 USD
Operating income
-15,327,086 USD
Net income
-15,191,095 USD
Operating cash flow
-13,862,441 USD